Paracrine pro-regenerative pathways

Paracrine pro-regenerative pathways represent the collective signaling mechanisms by which cells, particularly mesenchymal stem cells (MSCs) and other progenitor cells, secrete bioactive factors to orchestrate tissue repair and regeneration in neighboring cells (Circulation Research, 2008). This "paracrine hypothesis" posits that the therapeutic efficacy of stem cell therapies is primarily driven by the secretome—a complex mixture of growth factors, cytokines, and extracellular vesicles—rather than the direct differentiation of transplanted cells into host tissue (PMC, 2010). Key molecular mediators within these pathways include VEGF for angiogenesis, IGF-1 and HGF for cell survival, and IL-10 for immunomodulation and the resolution of inflammation (MDPI, 2023). These pathways are critical for recovery from ischemic injuries, such as myocardial infarction and stroke, and are also targeted in the treatment of chronic wounds and neurodegenerative conditions. Therapeutic strategies aiming to harness these pathways include the use of recombinant growth factors, conditioned media, or exosome-based delivery systems, which offer a cell-free alternative to traditional regenerative medicine (University of Eastern Finland, 2023). While not a single molecular target, these pathways represent a critical therapeutic focus for enhancing endogenous repair mechanisms.

Other names

Stem cell paracrine signalingPro-regenerative secretomeTrophic factor signalingParacrine hypothesis of stem cell therapyRegenerative paracrine signaling

Activation of endogenous repair and survival mechanisms through the secretion of bioactive molecules—including growth factors, cytokines, and extracellular vesicles—that act on neighboring cells to promote healing and reduce inflammation.